(Q46430033)

22 December 2017

title

Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes (English)

1 reference

22 December 2017

0 references

1 reference

Chan-Hee Jung

1

1 reference

22 December 2017

Bo-Yeon Kim

2

1 reference

22 December 2017

Chul-Hee Kim

3

1 reference

22 December 2017

Sung-Koo Kang

4

1 reference

22 December 2017

Sang-Hee Jung

5

1 reference

22 December 2017

Ji-Oh Mok

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

27 June 2013

1 reference

22 December 2017

Diabetes and Vascular Disease Research

published in

1 reference

22 December 2017

volume

10

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

459-467

1 reference

22 December 2017

Oxidative stress and diabetic complications

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Fetuin-A and incident diabetes mellitus in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Plasma fetuin-A levels and the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Serum fetuin-A is an independent marker of insulin resistance in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Fetuin-A induces cytokine expression and suppresses adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Fetuin-A and arterial stiffness in patients with normal kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113490766

21 January 2018

Identifiers

DOI

10.1177/1479164113490766

1 reference

22 December 2017

1 reference

22 December 2017